Euan Ashley on the Functional Landscape of Coding Variation in the FH Gene LDLR
Euan Ashley, Chair at Stanford Department of Medicine, Author of The Genome Odyssey, shared on LinkedIn:
”So excited about this new work from our CardioVar consortium out this week in Science Magazine led by the amazing Daniel Tabet, and Fritz Roth.
Familial hypercholesterolemia (FH) is among the most common inherited cardiovascular diseases.
It causes early heart attacks that are preventable with modern therapy and a genomics-forward strategy for family testing.
The challenge is that many variants identified by sequencing are of unclear significance.
The new science of “variant effect mapping” uses cellular biology to model all possible variants in important genes in advance, providing scientists and clinicians with estimates as to their pathogenicity.
Here, Daniel and team tested the impact of nearly all possible (~17,000) missense coding variants in the receptor for LDL (“bad cholesterol”), the gene most commonly responsible for FH.
Importantly, they tested two functional readouts: LDLR cell-surface abundance and LDL uptake.
This yielded sequence–function maps that recapitulate known biochemistry, offer functional insights, and provide evidence for interpreting clinical variants.
Further, functional scores correlated with hyperlipidemia phenotypes in prospective human cohorts and augmented polygenic scores to improve risk inference.
These sorts of maps will increasingly become central tools in our quest to understand disease-causing human genes to help patients and prevent disease.
Amazing work from Daniel, Fritz and team.
Paper.
Variant effect map review.
Cardiovar consortium.
Atlas of variant effect maps.”
Read the full article in Science.
Article: The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR
Authors: Anna Axakova, Euan Ashley, Mafalda Bourbon, Jack M. P. Castelli, Melina Claussnitzer, Elizabeth T. Cirulli, Atina G. Coté, Carmela Serio Carrero, Da Kuang, Daniel R. Tabet, Douglas M. Fowler, Iosifina Fotiadou, Aanshi Gandhi, Michael Garton, Andrew M. Glazer, Robert A. Hegele, Mohammad Majharul Islam, Jennifer J. Knapp, Joshua W. Knowles, Brett M. Kroncke, Nishka Kishore, Roujia Li, Megan C. Lancaster, Calum A. MacRae, Kenneth Matreyek, Ranim Maaieh, Victoria N. Parikh, Simon G. Pfisterer, Ashyad Rayhan, Dan M. Roden, Frederick P. Roth, Shahin Sowlati-Hashjin, Olivia Taverniti, Jochen Weile.
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 26, 2026, 17:33Melissa Bouchard: Navigating Prosthetic Valves and Anticoagulation in Pregnancy at ACHD Hive Talks
-
Mar 26, 2026, 17:25Yonah S. Tehrani: Providing Clarity for Anticoagulant Selection in Acute Venous Thromboembolism
-
Mar 26, 2026, 17:18Casey Laycock: Spotlight on Community Champion – Jon Schneider of Spire
-
Mar 26, 2026, 17:16Rebecca Mellema: Journal Club Spotlight on Layilin and Platelet Hyperactivation in Inflammatory Bowel Disease
-
Mar 26, 2026, 17:15Shalom Zwiebel: Clinical Practice Evaluating PRP Systems and Supply Partners
-
Mar 26, 2026, 17:14Olivia C.: Pfizer’s mRNA BNT162b2 Vaccine Does Not Induce High Levels of Inflammation
-
Mar 26, 2026, 17:03Tilden Sokoloff: PRP Injections Enhance Sexual Function in Premenopausal Women
-
Mar 26, 2026, 17:02Mahesan Subramaniam: Japan Brings Mitochondrial Therapy to the Frontline of Cardiology
-
Mar 26, 2026, 17:01Kanishk Kumar: Discovering The Newest Advances in Hypercholesterolemia Research